• FirefoxInstall the new Firefox »
  •  Dow Up 0.22% Nasdaq Up 0.64%

    Chimerix, Inc. (CMRX)

    -NasdaqGM
    37.08 Up 0.53(1.45%) 3:52PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:36.55
    Open:36.56
    Bid:37.05 x 100
    Ask:37.09 x 200
    1y Target Est:50.56
    Beta:1.017
    Earnings Date:May 7 - May 11 (Est.)
    Day's Range:36.10 - 37.63
    52wk Range:14.02 - 43.41
    Volume:253,705
    Avg Vol (3m):458,172
    Market Cap:1.52B
    P/E (ttm):N/A
    EPS (ttm):-1.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CMRXUp 1.45%1.52B
    GNBTDown 5.31%N/A
    GILDUp 0.23%150.89B
    SIGA 0.00%109.68M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):371.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.52
    Quarterly EPS Est (Mar-15) :-0.57
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral antivirals to address unmet medical needs in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback